Fifty Years of Research and One Conclusion: Opium Causes Cancer

Mahdi Sheikh ^1,2, Farin Kamangar ³, Reza Malekzadeh ^2,4 *

Cited by CrossRef: 8

1- Haque M, Barlass U, Armstrong A, Shaikh M, Bishehsari F. Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression. Mol Cell Biochem. 2022;477(5):1339 [Crossref]

2- Ghouchani H, Lashkardoost H, Saadati H, Hojjat S, Kaviyani F, Razaghi K, Asghari D, Gholizadeh N. Developing and validating a measurement tool to self-report perceived barriers in substance use treatment: the substance use treatment barriers questionnaire (SUTBQ). Subst Abuse Treat Prev Policy. 2021;16(1) [Crossref]

3- Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A, Nemati S, Khoshnia M, Gharavi A, Roshandel G, Hashemian M, Dawsey S, Abnet C, Brennan P, Boffetta P, Zendehdel K, Kamangar F, Malekzadeh R, Sheikh M. Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. eClinicalMedicine. 2023;64:102229 [Crossref]

4- Mardi P. Opium abuse and stroke in Iran: A systematic review and meta-analysis. Front Neurol. 2022;13 [Crossref]

5- Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, Abdi S, Nahvijou A, Kamangar F, Roshandel G, Ghanbari Motlagh A, Pourshams A, Poustchi H, Haghdoost A, Najafi F, Sheikh M, Malekzadeh R, Zendehdel K. Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. Intl Journal of Cancer. 2023;153(10):1758 [Crossref]

6- Nemati S, Dardashti A, Mohebbi E, Kamangar F, Malekzadeh R, Zendehdel K, Sheikh M. Potential impact of controlling opium use prevalence on future cancer incidence in Iran. eClinicalMedicine. 2024;73:102650 [Crossref]

7- Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, Safari-Faramani R, Seyyedsalehi M, Hosseini B, Bakhshi M, Alizadeh-Navaei R, Ahmadi L, Rezaianzadeh A, Moradi A, Ansari-Moghaddam A, Nejatizadeh A, ShahidSales S, Zohrabi F, Mohammadi R, Nowroozi M, Poustchi H, Nasrollahzadeh D, Najafi F, Haghdoost A, Rahimi-Movaghar A, Etemadi A, Mohagheghi M, Malekzadeh R, Brennan P, Schüz J, Boffetta P, Weiderpass E, Kamangar F, Zendehdel K, Pukkala E. Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. 2022;51(3):830 [Crossref]

8- Mohebbi E, Alimoradi Z, Rozek L, Mohebbi A, Jafari E. Risk of head and neck cancer among opium users. Archives of Oral Biology. 2024;157:105846 [Crossref]

9- Naghibzadeh-Tahami A, Marzban M, Yazdi-Feyzabadi V, Khazaei Z, Zahedi M, Moazed V, Haghdoost A. Opium use as an independent risk factor for pancreatic cancer: A case-control study. Cancer Epidemiology. 2021;75:102017 [Crossref]

10- Nemati S, Islami F, Kamangar F, Poustchi H, Roshandel G, Shakeri R, Domingues A, Khoshnia M, Gharavi A, Brennan P, Abnet C, Dawsey S, Boffetta P, Malekzadeh R, Sheikh M, Mansouri B. Improvement of esophageal cancer survival in Northeast Iran: A two-decade journey in a high-risk, low- resource region. PLoS ONE. 2024;19(9):e0310842 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.